Tuesday, June 22, 2021 6:48:21 PM
-Redemsivir with Baricitinib request filed 10/07/20, approved 11/19/20 (44 days or 6 weeks, 2 days)
-Casirivimab with Imdevimab request filed 10/09/20, approved 11/21/20 (44 days or 6 weeks, 2 days)
-Bamlanivimab request filed 10/08/20, approved 11/09/20. (33 days or 4 weeks, 5 days)
-Bamlanivimab and Etesevimab -
Blaze Trial ended 1/26/2021 EUA approved 02/09/2021. (15 days from trials end)
-Sotrovimab filed 3/10/ 2021 or later in March, approved 5/26/2021 (78 days or 11 weeks + 1 day)
So we have 44 days twice, 33 days 78 days (or less), 15 days from end of a trial.
~ Money Making Money ~
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM